|
Market Cap (3-Jul) $77,366,520 (1,153rd) |
Close (30-Jun) $0.025 |
Volume (30-Jun) 981,823 |
Shortsold (10-Jun) 33,792 (0.00%) (569th) |
|
52w High $0.060 |
52w Low $0.024 |
P/E - |
EPS -0.01 |
PCK released this announcement to the ASX on 29 April 2021, 8:11. The announcement is marked as price sensitive, and is 12 page(s) in length and 371.06kb in size.
You can view all announcements from PCK and see how they appear on a price chart on the announcements page.
At the date of this announcement, PCK was 0.256% short sold according to ASIC data. It was ranked the 360th most shorted stock on the ASX. It remains ranked 569th as of the latest reported data (10 June 2025).
| Other Recent Announcements from PCK | |
|---|---|
| Ethos Laboratories Distribution Agreement | 15 June 2023, 10:52 |
| Investor Presentation Webinar | 2 May 2023, 8:31 |
| Quarterly Investor Webinar - Tuesday 2 May | 28 April 2023, 16:30 |
| March 2021 Quarterly Update | 29 April 2021, 8:11 |
| Appendix 4C - quarterly | 29 April 2021, 8:10 |
| PainChek receives CE Mark & TGA clearance for Universal App | 17 March 2021, 8:21 |
| PainChek to present at NWR Virtual Investor Conference | 16 March 2021, 8:18 |
You must be logged in to post a reply.
PainChek 